Please assess the completion status of the following clinical trial:

Trial Title: ECM and Blood Components for Wound Healing

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Type 1 or Type 2 diabetes, and/or venous insufficiency to the affected leg~* Ulcer has been present between 12 and 52 weeks~* Ulcer is less than 40 cm2 in area~Exclusion Criteria:~* Less than 18 years of age~* Pregnant or planning to become pregnant during the study period~* Simultaneously participating in another investigational drug or device study~* Unable or unwilling to comply with the weekly study follow-up schedule or off-loading regimen~* Patient or legal representative refuses to sign the EC-approved informed consent form~* Known allergy to pig or porcine products~* Additional criteria may apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ECM in Saline (Type: EXPERIMENTAL): None
- Blood Products (Type: ACTIVE_COMPARATOR): None
- ECM in Blood Products (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).